References

Ajaal, T.T. and R.W. Smith, 2009. Employing the Taguchi method in optimizing the scaffold production process for artificial bone grafts. J. Mater. Process. Technol., 209: 1521-1532.
CrossRef  |  

Buck, B.E., T.I. Malinin and M.D. Brown, 1989. Bone transplantation and human immunodeficiency virus: An estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin. Orthopae. Related Res., 240: 129-136.
Direct Link  |  

Burg, K.J.L., S. Porter and J.F. Kellam, 2000. Biomaterial developments for bone tissue engineering. Biomaterials, 21: 2347-2359.
CrossRef  |  

Deie, M., M. Ochi, N. Adachi, M. Nishimori and K. Yokota, 2008. Artificial bone grafting [calcium hydroxyapatite ceramic with an interconnected porous structure (IP-CHA)] and core decompression for spontaneous osteonecrosis of the femoral condyle in the knee. Knee Surg. Sports Traumatol. Arthrosc., 16: 753-758.
CrossRef  |  

Du, C., F.Z. Cui, Q.L. Feng, X.D. Zhu and K. De Groot, 1998. Tissue response to nano-hydroxyapatite/collagen composite implants in marrow cavity. J. Biomed. Mater. Res., 42: 540-548.
CrossRef  |  

Harada, Y., 1989. Experimental studies of healing process on compound blocks of hydroxyapatite (HAP) particles and tricalcium phosphate (TCP) powder implantation in rabbit mandible-comparison of HAP/TCP ratios and plastic methods. Shika Gakuho, 89: 263-297 (In Japanese).
PubMed  |  

Kessler, P., M. Thorwarth, A. Bloch-Birkholz, E. Nkenke and F.W. Neukam, 2005. Harvesting of bone from the iliac crest-comparison of the anterior and posterior sites. Br. J. Oral Maxillofacial Surg., 43: 51-56.
CrossRef  |  

Kim, I.Y., S.J. Seo, H.S. Moon, M.K. Yoo, I.Y. Park, B.C. Kim and C.S. Cho, 2008. Chitosan and its derivatives for tissue engineering applications. Biotechnol. Adv., 26: 1-21.
CrossRef  |  Direct Link  |  

Lee, W.S., Y. Suzuki, S.S. Graves, M. Iwata and G.M. Venkataraman et al., 2011. Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation. Biol. Blood Marrow Transplant., 17: 465-475.
CrossRef  |  

Rao, R.R., H.N. Roopa and T.S. Kannan, 1997. Solid state synthesis and thermal stability of HAP and HAP-β-TCP composite ceramic powders. J. Mater. Sci.: Mater. Med., 8: 511-518.
CrossRef  |  

Roobrouck, V.D., C. Clavel, S.A. Jacobs, F. Ulloa-Montoya and S. Crippa et al., 2011. Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem Cells, 29: 871-882.
CrossRef  |  

Simonds, R.J., S.D. Holmberg, R.L. Hurwitz, T.R. Coleman and S. Bottenfield et al., 1992. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N. Engl. J. Med., 326: 726-732.
Direct Link  |  

Tomihata, K. and Y. Ikada, 1997. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials, 18: 567-575.
CrossRef  |  

Younger, E.M. and M.W. Chapman, 1989. Morbidity at bone graft donor sites. J. Orthopae. Trauma, 3: 192-195.
Direct Link  |  

Yu, J., M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget and J.L. Frane et al., 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science, 318: 1917-1920.
CrossRef  |  Direct Link  |  

Zhu, X.Q., X.H. Pan, W. Wang, Q. Chen and R.Q. Pang et al., 2010. Transient in vitro epigenetic reprogramming of skin fibroblasts into multipotent cells. Biomaterials, 31: 2779-2787.
CrossRef  |